References
Acero, R, Polentarutti, N, Bottazzi, B, Alberti, S, Ricci, MR, Bizzi, A, Mantovani, A: Effect of hydrocortisone on the macrophage content, growth and metastasis of transplanted murine tumors. Int J Cancer 33: 95–105, 1984
Adams, DO, Snyderman, R: Do macrophages destroy nascent tumors? JNCI 62: 1341–1345, 1979
Alexander, P, Eccles, SA, Gauci, CLL: The significance of macrophages in human and experimental tumours. Ann NY Acad Sci 276: 124–133, 1976
Ando, M, Dannenberg, AMJr: Macrophage accumulation, division, maturation, and digestive microbicidal capacities in tuberculous lesions. IV. Macrophage turnover, lysosomal enzymes, and division in healing lesions. Lab Invest 27: 466–472, 1972
Argyris, TS, Slaga, TJ: Promotion of carcinomas by repeated abrasion in initiated skin of mice. Cancer Res 41: 5193–5195, 1981
Bear, RHJr, Roholt, OA, Pressman, D: Syngeneic tumor rejection induced by immunization with allogeneic tissues. Immunologic Communications 6: 217–225, 1977
Besedovsky, HO, del, Rey, A, Sorkin, E: Lymphokine containing supernatants from Con-A stimulated cells increase corticosterone blood levels. J Immunol 126: 385–387, 1981
Besedovsky, HO, del, Rey, AE, Sorkin, E: What do the immune system and the brain know about each other? Immunology Today 4: 342–346, 1983
Besedovsky HO, del Rey A, Schardt M, Sorkin E, Normann S, Baumann J, Girard J: Changes in plasma hormone profiles after tumor transplantation into syngeneic and allogeneic rats. Int J Cancer (in press), 1985
Bernstein, ID, Zbar, B, Rapp, HJ: Impaired inflammatory response in tumor-bearing guinea pigs. J Natl Cancer Inst 49: 1641–1647, 1972
Boetcher, DA, Leonard, EJ: Abnormal monocyte chemotactic response in cancer patients. J Natl Cancer Inst 52: 1091–1099, 1974
Bottazzi, B, Polentarutti, N, Acero, R, Balsari, A, Borachi, D, Ghezzi, P, Salmona, M, Mantovani, A: Regulation of the macrophage content of neoplasms by chemoattractants. Science 220: 208–210, 1983
Brown, JP, Klitzman, JM, Hellstrom, I, Nowinski, RC, Hellstrom, KE: Antibody response of mice to chemically induced tumors. Proc Natl Acad Sci (USA) 75: 955–958, 1978
Bugelski, PJ, Kirsh, RL, Poste, G: New histochemical method for measuring intratumoral macrophages and macrophage recruitment into experimental metastases. Cancer Research 43: 5493–5501, 1983
Bugelski, PJ, Corwin, JM, Sowinski, JM, Kirsh, R, Poste, G: Changes in the macrophage density in growing metastases. J Leukocyte Biology 36: 212–213, 1984
Bugelski, PJ, Kirsh, RL, Sowinski, JM, Poste, G: Changes in the macrophage content of lung metastases at different stages in tumor growth. Am J Path 118: 419–424, 1985
Cheung, HT, Cantarow, WD, Sundharadas, G: Characteristics of a low-molecular weight factor extracted from mouse tumors that affects in vitro properties of macrophages. Int J Cancer 23: 344–352, 1979
Chirigos, MA, Schultz, RM, Stylos, WA: Interactions of interferon, macrophage and lymphocyte tumoricidal activity with prostaglandin effect. Annals New York Acad Sci 350: 91–101, 1980
Cianciolo, GJ, Herberman, RB, Snyderman, R: Depression of murine macrophage accumulation by low-molecular-weight factors derived from spontaneous mammary carcinoma. J Natl Cancer Inst 65: 829–834, 1980a
Cianciolo, GJ, Matthews, TJ, Bolognesi, DP, Snyderman, R: Macrophage accumulation in mice is inhibited by low molecular weight products from murine leukemia viruses. J Immunol 124: 2900–2905, 1980b
Cianciolo, GJ, Hunter, J, Silva, J, Haskill, JS, Snyderman, R: Inhibitors of monocyte responses to chemotaxis are present in human cancerous effusions and react with monoclonal antibodies to P15(E) structural protein of retroviruses. J Clin Invest 68: 831–844, 1981
Constantian, MB, Menzoian, JO, Nimberg, RB, Schmid, K, Mannick, JA: Association of a circulating immunosuppressive polypeptide with operative and accidental trauma. Ann Surg 185: 73–79, 1977
Currie, GA: Promotion of fibrosarcoma cell growth by products of syngeneic host macrophages. Br J Cancer 44: 506–513, 1981
Dannenberg, AMJr: The anti-inflammatory effects of glucocorticosteroids: A brief review of the literature. Inflammation 3: 329–343, 1979
DeLustro, G, Argyris, BF: Mastocytoma-mediated suppression of mixed lymphocyte culture and mitogen responsiveness. Cellular Immunology 21: 177–184, 1976
Eccles SA: Studies on the effects of rat sarcomata on the migration of mononuclear phagocytes in vitro and in vivo. In: James K, McBride B, Stuart A (eds): The Macrophage and Cancer. Econoprint, Edinburgh. pp 308–320
Eccles, SA, Alexander, P: Macrophage content of tumours in relation to metastatic spread and host immune reaction. Nature 250: 667–669, 1974
Estes, JE, Pledge, WJ, Gillespie, GY: Macrophage-derived growth factor for fibroblasts and interleukin-I are distinct entities. J Leukocyte Biol 35: 115–130, 1984
Evans, R: Macrophages in syngeneic animal tumors. Transplantation 14: 468–473, 1972
Evans, R: Macrophage requirement for growth of a murine fibrosarcoma. Br J Cancer 37: 1086–1089, 1978
Evans, R: Macrophage accumulation in primary and transplanted tumors grown in C5 deficient B10.D2/oSe mice. Int J Cancer 26: 227–229, 1980
Evans, R, Lawler, EM: Macrophage content and immunogenicity of C57BL/6J and BALB/cByJ methylcholanthrene-induced sarcomas. Int J Cancer 26: 831–835, 1980
Evans, R, Eidlen, DM: Macrophage accumulation in transplanted tumors is not dependent on host immune responsiveness or presence of tumor-associated rejection antigens. J Reticuloendothelial Soc 30: 425–437, 1981
Evans, R, Eidlen, DM: Intratumor and peritoneal inflammatory responses in relation to tumor burden and age of mouse. J Reticuloendothelial Soc 32: 101–110, 1982a
Evans, R, Eidlen, LG: The role of the inflammatory response during tumor growth. In: Normann, S, Sorkin, E (eds): Macrophages and Natural Killer Cells: Regulation and Function. New York: Plenum Publishing Co. pp 379–387, 1982b
Evans, R, Cullen, RT: In situ proliferation of intratumor macrophages. J Leukocyte Biol 35: 561–572, 1984
Fauve, RM, Hevin, B, Jacob, H, Gaillard, JA, Jacob, F: Anti-inflammatory effects of murine malignant cells. Proc Natl Acad Sci (USA) 71: 4052–4056, 1974
Fidler, IJ, Barnes, Z, Fogler, WE, Kirsh, R, Bugelski, P, Poste, G: Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators. Cancer Research 42: 496–501, 1982
Fogler, WE, Fidler, IJ: Nonselective destruction of murine neoplastic cells by syngeneic tumoricidal macrophages. Cancer Research 45: 14–18, 1985
Gabizon, A, Lelbovich, SJ, Goldman, R: Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo. JNCI 65: 913–920, 1980
Gillis, S, Crabtree, GR, Smith, K: Glucocorticoid induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation. J Immunol 123: 1624–1631, 1979
Gorelik, E, Segal, S, Feldman, M: Growth of a local tumor exerts a specific inhibitory effect on progression of lung metastasis. Int J Cancer 21: 617–625, 1978
Hopper DG, Pimm MV: Macrophages v Cancer Lancet July pp 255–256, 1976
Ioachim HL: Correlations between tumor antigenicity, malignant potential, and local host immune response. In: Witz IP, Hanna MG Jr (eds): Contemporary Topics in Immunobiology. 10: 213–238, 1980
Ioachim, HL, Dorsett, B, Paluch, E: The immune response at the tumor site in lung carcinoma. Cancer 38: 2296–2309, 1976
Inoue, Y, Nelson, DS: Modulation of natural and acquired immunity of rats to tumour isografts. Aust J Exp Biol Med Sci 62:(part 2) 167–180, 1984
Israel, L, Samak, R, Edelstein, R, Amouroux, J, Battesti, J-P, de, Saint Florent, G: In vivo nonspecific macrophage chemotaxis in cancer patients and its correlation with extent of disease, regional lymph node status and disease-free survival. Cancer Research 42: 2489–2494, 1982
Jacquemin, PC: Expression of type C viral glycoproteins on P815 cells: Higher expression of Mr 70,000 glycoprotein-containing glycoprotein on immunogenic variants. Cancer Research 42: 3828–3836, 1982
Kadhim, SA, Rees, RC: Enhancement of tumor growth in mice: evidence for the involvement of host macrophages. Cellular Immunology 87: 259–269, 1984
Keller, R: Macrophages in primary and secondary tumor growth: some implications for cancer therapy. Biomedicine and Pharmacotherapy 39: 7–12, 1985
Key, M, Talmadge, JE, Fidler, IJ: Lack of correlation between the progressive growth of spontaneous metastases and their content of infiltrating macrophages. J Reticuloendothelial Soc 32: 387–396, 1982
Lane, RD, Kaplan, AM, Snodgrass, MJ, Szala, AK: Characterization of a macrophage chemokinetic factor in tumor cell culture media. J Reticuloendothelial Soc 31: 171–184, 1982
Mariano, M, Spector, WG: The formation and properties of macrophage polykaryons (inflammatory giant cells). The Journal of Pathology 113: 1–19, 1974
Mathes, LE, Olsen, RG, Hebebrand, LC, Hoover, EA, Schaller, JP, Adams, PW, Nichols, WS: Immunosuppressive properties of a virion polypeptide, a 15,000 dalton protein, from feline leukemia virus. Cancer Research 39: 950–955, 1979
McLoughlin, GA Wu, AV, Saporoschetz, I, Nimberg, R, Mannick, JA: Correlation between anergy and a circulating immunosuppressive factor following major surgical trauma. Ann Surg 190: 297–304, 1979
Metcalf, D: Regulation of macrophage production. In: Normann, S, Sorkin, E (eds): Macrophage and Natural Killer Cells: Regulation and Function. Plenum Press, New York, pp 33–48, 1982
Meltzer, MS, Stevenson, MM, Leonard, EJ: Characterization of macrophage chemotaxins in tumor cell cultures and comparisons with lymphocyte-derived chemotactic factors. Cancer Research 37: 721–725, 1977
Moore, K, Moore, M: Intratumor host cells of transplanted rat neoplasms of different immunogenicities. Int J Cancer 19: 803–813, 1977
Nakamura, M, Ishida, N, Kamo, I: Immunosuppressive factors from mastocytoma cells cultured in serum-free medium. J Natl Cancer Inst 65: 759–767, 1980
Nelson, M, Nelson, DS: Macrophages and resistance to tumors. I. Inhibition of delayed-type hypersensitivity reactions by tumor cells and by soluble products affecting macrophages. Immunology 34: 277–290, 1978
Nelson, M, Nelson, DS: Macrophages and resistance to tumors. IV. The influence of age on the susceptibility of mice to the anti-inflammatory and anti-macrophage effects of tumor cell products. J Natl Cancer Inst 65: 781–789, 1980
Nelson, M, Nelson, DS: Macrophages and resistance to tumors. 6. The effects of supernatants from cultures of normal and tumor cells on phagocytosis. J Reticuloendothelial Soc 31: 433–450, 1982
Nelson, DS, Nelson, M, Farram, E, Inque, Y: Cancer and subversion of host defenses. Aust J of Exp Biol Med Sci 59: 229–262, 1981
Nestel, FP, Casson, PR, Wiltrout, RH, Kerbel, RS: Alterations in sensitivity to nonspecific cell-mediated lysis associated with tumor progression: Characterization of activated macrophage and natural killer cell resistant tumor variants. JNCI 73: 483–491, 1984
Nolibe, D, Masse, R, Giroud, JP: Effect of tumour growth on inflammatory macrophages In: Willoughby, DA, Giroud, JP (eds): Inflammation: Mechanisms and Treatment. MTP Press, Lancaster, pp 675–682, 1980
Normann, SJ: Tumor cell threshold required for suppression of macrophage inflammation. J Natl Cancer Inst 60: 1091–1096, 1978
Normann, SJ, Cornelius, J: Concurrent depression of tumor macrophage infiltration and systemic inflammation by progressive cancer growth. Cancer Research 38: 3453–3459, 1978
Normann, SJ, Cornelius, J: Characterization of anti-inflammatory factors produced by murine tumor cells in culture. JNCI 69: 1321–1327, 1982
Normann, SJ, Schardt, M, Sorkin, E: Cancer progression and monocyte inflammatory dysfunction: relationship to tumor excision and metastasis. Int J Cancer 23: 110–113, 1979a
Normann, SJ, Schardt, M, Sorkin, E: Anti-inflammatory effect of spontaneous lymphoma in SJL/J mice. J Natl Cancer Inst 63: 825–833, 1979b
Normann, SJ, Schardt, M, Sorkin, E: Alteration of macrophage function in AKR leukemia. J Natl Cancer Inst 66: 157–162, 1981a
Normann, SJ, Schardt, M, Sorkin, E: Biphasic depression of macrophage function after tumor transplantation. Int J Cancer 28: 185–190, 1981b
Normann, SJ, Schardt, M, Sorkin, E: Effect of pregnancy on cellular inflammation. Brit J Exp Path 63: 432–437, 1982
Normann, SJ, Schardt, MC, Sorkin, E: Macrophage inflammatory responses in rats and mice with autochthonous and transplanted tumors induced by 3-methylcholanthrene. J Natl Cancer Inst 72: 175–184, 1984
Normann, SJ, Schardt, M, Sorkin, E: Autochthonous murine tumors: effects of viral or ultraviolet induction, immunogenicity and transplantation on intratumoral macrophages and systemic inflammatory responses. Eur J Cancer 21: 119–125, 1985a
Normann, SJ, Schardt, M, Sorkin, E: Anti-leukocyte activity. I. Systemic inhibition of cellular emigration following local inflammation. J Leukocyte Biol 37: 319–330, 1985b
Normann, SJ, Schardt, M, Sorkin, E: Anti-leukocyte activity. II. Induction of tolerance to systemic anti-inflammation associated with local irritation and major surgery. J Leukocyte Biol 37: 331–339, 1985c
Normann, SJ, Sorkin, E: Cell-specific defect in monocyte function during tumor growth. J Natl Cancer Inst 57: 135–140, 1976
Normann, SJ, Sorkin, E: Inhibition of macrophage chemotaxis by neoplastic and other rapidly proliferating cells in vitro. Cancer Research 37: 705–711, 1977
Normann, SJ, Weiner, R: Cytotoxicity of human peripheral blood monocytes. Cellular Immunology 81: 413–425, 1983
Pasternack, GR, Snyderman, R, Pike, MC, Johnson, RJ, Shin, HS: Resistance of neoplasms to immunological destruction: Role of a macrophage chemotaxis inhibitor. J Exp Med 148: 93–102, 1978
Pike, MC, Snyderman, R: Depression of macrophage function by a factor produced by neoplasms: a mechanism of abrogation of immune surveillance. J Immunol 117: 1243–1249, 1976
Polverini, PJ, Cotran, RS, Gimbron, MAJr, Unanue, ER: Activated macrophages induce vascular proliferation. Nature 269: 804–806, 1977
Poste, G, Kirsh, R: Rapid decay of tumoricidal activity and loss of responsiveness to lymphokines in inflammatory macrophages. Cancer Research 39: 2582–2590, 1979
Plescia, OJ, Smith, AH, Grinwish, K: Subversion of immune system by tumor cells and role of prostaglandins. Proc Natl Acad Sci USA 72: 1848–1851, 1975
Riley, V: Lactate dehydrogenase in the normal and malignant state in mice and the influence of a benign enzyme-elevating virus. In: Busch, H (ed): Methods in Cancer Research. Academic Press, New York Vol. 4: 493–618, 1968
Rinehart, JJ, Sagone, AL, Balcerzak, SP, Ackerman, GA, LoBuglio, AF: Effect of corticosteroid therapy on human monocyte function. New Eng J Med 292: 236–241, 1975
Rolland, PH, Martin, PM, Jacaueimier, J, Rolland, AM, Toga, M: Prostaglandin in human breast cancer: evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. JNCI 64: 1061–1070, 1980
Ruco, LP, Meltzer, MS: Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD stimulated Bacillus Calmette-Guerin immune spleen cell cultures. J Immunol 9: 889–896, 1977
Ruco, LP, Meltzer, MS: Macrophage activation for tumor cytotoxicity: increased lymphokine responsiveness of peritoneal macrophages during acute inflammation. J Immunol 120: 1054–1062, 1978
Russell, SW, Gillespie, GY, Pace, JL: Evidence for mononuclear phagocytes in solid neoplasms and appraisal of their nonspecific cytotoxic capabilities. In: Witz, IP, Hanna, MGJr (eds): Contemporary Topics in Immunobiology. Plenum Press, New York. 10: 143–176, 1980
Schradt, M, Normann, SJ, Sorkin, E: Dissociation of leukocyte chemotactic and inflammatory responses. Int Arch of Allergy and App Immunol 75: 68–74, 1984
Schultz, RM, Pavlidis, N, Stylos, WA, Chirigos, MA: Regulation of macrophage tumoricidal function: a role for prostaglandins of the E series. Science 202: 320–321, 1978
Snyder, DS, Lu, CY, Unanue, ER: Control of macrophage Ia expression in neonatal mice — role of a splenic suppressor cell. J Immunol 128: 1458–1465, 1982
Snyderman, R, Cianciolo, GJ: Further studies of a macrophage chemotaxis inhibitor (MCI) produced by neoplasms: Murine tumors free of lactic dehydrogenase virus produce MCI. J Reticuloendothelial Soc 26: 453–458, 1979
Snyderman, R, Meadows, L, Holder, W, Wells, SJr: Abnormal monocyte chemotaxis in patients with breast cancer: Evidence for a tumor-mediated effect. J Natl Cancer Inst 60: 737–740, 1978
Snyderman, R, Pike, MC, Blaylock, BL, Weinstein, P: Effect of neoplasms on inflammation: depression of macrophage accumulation after tumor implantation. J Immunol 116: 585–589, 1976
Snyderman, R, Seigler, HF, Meadows, L: Abnormalities of monocyte chemotaxis in patients with melanoma: Effects of immunotherapy and tumor removal. J Natl Cancer Inst 58: 37–41, 1977
Stahl, KW, Hevin, B, Fauve, RM: Purification and gel filtration chromatography (GFC) of an anti-inflammatory and macrophagotoxic peptide from murine malignant cells. In: James, K, McBride, B, Stuart, A (eds): The Macrophage and Cancer. Econopress, Edinburgh, pp 271–280, 1977
Stevenson, MM, Rees, JC, Meltzer, MS: Macrophage function in tumor-bearing mice: evidence for lactic dehydrogenase virus-associated changes. J Immunol 124: 2892–2899, 1980
Stewart, CC: Local proliferation of mononuclear phagocytes in tumors. J Reticuloendothelial Soc 34: 23–27, 1983
Stosic-Grujicic, S, Simic, MM: Modulation of interleukin 1 production by activated macrophages: In vitro action of hydrocortisone, colchicine and cytochalasin B. Cellular Immunology 69: 235–247, 1982
Stutman, O: Delayed tumour appearance and absence of regression in nude mice infected with murine sarcoma virus. Nature 253: 142–144, 1975
Szymaniec, S, James, K: Studies on the Fc receptor bearing cells in a transplanted methylcholanthrene induced mouse fibrosarcoma. Br J Cancer 33: 36–49, 1976
Taffet, SM, Russell, SW: Macrophage-mediated tumor cell killing: Regulation of expression of cytolytic activity by prostaglandin E. J Immunol 126: 424–427, 1981
Talmadge, JE, Key, M, Fidler, IJ: Macrophage content of metastatic and nonmetastatic rodent neoplasms. J Immunol 126: 2245–2248, 1981
Urban, JL, Schreiber, H: Selection of macrophage-resistant progressor tumor variants by the normal host: Requirement for concomitant T cell-mediated immunity. J Exp Med 157: 642–656, 1983
Valone, FH: Quantitation of arachidonic acid lipoxygenase products in malignant and nonmalignant effusions. Cancer Research 43: 5695–5698, 1983
Van den, Brenk, HAS, Stone, M, Kelly, H, Orton, C, Sharpington, C: Promotion of growth of tumour cells in acutely inflamed tissues. Br J Cancer 30: 246–260, 1974
Warabi, H, Venkat, K, Geetha, V, Liotta, LA, Brownstein, M, Schiffmann, E: Identification and partial characterization of a low molecular-weight inhibitor of leukotaxis from fibrosarcoma cells. Cancer Research 44: 915–922, 1984
Watanabe, M, Pan, S-H, Friedman, H: Serologic and immunochemical characterization of an immunosuppressive soluble factor from mastocytoma-bearing mice. J Natl Cancer Inst 61: 249–254, 1978
Wood, GW, Gillespie, GY: Studies on the role of macrophages in regulation of growth and metastasis of murine chemically induced fibrosarcomas. Int J Cancer 16: 1022–1029, 1975
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Normann, S.J. Macrophage infiltration and tumor progression. Cancer Metast Rev 4, 277–291 (1985). https://doi.org/10.1007/BF00048093
Issue Date:
DOI: https://doi.org/10.1007/BF00048093